Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-05-19 @ 9:16 AM
Study NCT ID:
NCT01637532
Status:
COMPLETED
Last Update Posted:
2016-01-26
First Post:
2012-04-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer
Sponsor:
Leiden University Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PITCH trial
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |